Who founded Seremedi?

Seremedi was founded by Kim Bond Evans in 2014.

Who are Seremedi's investors?

Seremedi's investors include Techstars.

How much funding has Seremedi raised?

Seremedi has disclosed $200K raised across 1 round.

Where is Seremedi headquartered?

Seremedi is headquartered in Houston, US.

Seremedi

Techstars '17

Houston, US · Founded 2014 · Delaware corporation · 5 employees on LinkedIn · 1 known investors

Find your way into Seremedi

589 people in our graph share verified history with the Seremedi team — schools, employers, funds. One of them is your warm intro.

Houman Haghighiunlockedknows Kim Bond Evans · together at Techstars (overlapped)

×7knows the team · via Techstars

×3knows the team · via University of Florida

knows the team · via Wayne State University

Seremedi provides a digital app that guides post-procedure care for aesthetic procedures, offering personalized care plans for clients and documentation tools for nurses and care providers.

Digital Health Healthtech SaaS

Founders & leadership

Seremedi was founded in 2014 by Kim Bond Evans.

Kim Bond Evans inFounderKim Bond Evans has held executive roles including CEO and President of patient advocacy firm Karis, President of cybersecurity company Blue Lance, CEO of Secure Vantage Technologies, and co-founder of application management company Covasoft, alongside earlier experience at Microsoft and BMC, Inc. She is now Executive Officer and Director at Seremedi, which provides digital guidance and documentation tools for post-procedure aesthetic care recovery and clinical trial coordination.

David MiddletonExecutive

Andre Pontin inVice President of Sales and Business Development2015–2017André Pontin is an Executive Officer at Seremedi, a digital health platform offering post-procedure care guidance and documentation tools for aesthetic procedures. He has worked in healthcare technology and digital health strategy, and serves on the National Cancer Institute's SBIR executive roundtable.

Nicholas RockecharlieExecutive

Felicity McGourtyinChief Operating Officer

Melanie Achard inVice President of Products2014–2020Melanie Achard has senior product management and marketing experience across application performance monitoring, healthcare, and security sectors, with expertise in product strategy, SaaS, and business development. She is Executive Officer at Seremedi, which provides a digital app that guides post-procedure care for aesthetic procedures.

Cody MenardNamed on SEC filing

Board

Alex BentonBoard director

Investors · 1

TechstarsBoulder · $220K

Reported raises · per SEC filings

Form D private placements

$200K disclosed across 1 round · 2016

▶$200KraisedJan 2017 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

David MiddletonExecutive Officer
Cody MenardExecutive Officer, Director, Promoter
Andre PontinExecutive Officer
Kim Bond EvansExecutive Officer, Director, Promoter
Nicholas RockecharlieExecutive Officer, Director
Felicity McGourtyExecutive Officer
Alex BentonDirector
Melanie AchardExecutive Officer

Offering amount: $3M
Amount sold: $200K
Minimum investment: $100K
Proceeds to insiders: $1M
First sale: Dec 2016
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b, 4a5

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Seremedi do?: Seremedi provides a digital app that guides post-procedure care for aesthetic procedures, offering personalized care plans for clients and documentation tools for nurses and care providers.
Who founded Seremedi?: Seremedi was founded by Kim Bond Evans in 2014.
Who are Seremedi's investors?: Seremedi's investors include Techstars.
How much funding has Seremedi raised?: Seremedi has disclosed $200K raised across 1 round.
Where is Seremedi headquartered?: Seremedi is headquartered in Houston, US.